Qingdao Vland Biotech INC.
SSE:603739.SS
13.97 (CNY) • At close June 9, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 1,320.761 | 1,198.902 | 1,163.163 | 1,150.824 | 960.249 | 846.778 | 813.971 | 799.44 | 781.23 | 751.724 | 728.223 |
| Kosten van de omzet
| 725.809 | 644.687 | 660.311 | 618.507 | 492.334 | 437.069 | 409.565 | 384.612 | 353.972 | 359.649 | 326.571 |
| Brutowinst
| 594.952 | 554.215 | 502.852 | 532.316 | 467.915 | 409.709 | 404.406 | 414.828 | 427.258 | 392.074 | 401.652 |
| Brutowinstmarge
| 0.45 | 0.462 | 0.432 | 0.463 | 0.487 | 0.484 | 0.497 | 0.519 | 0.547 | 0.522 | 0.552 |
| Onderzoek- en ontwikkelingskosten
| 118.222 | 110.682 | 102.397 | 100.937 | 79.913 | 74.998 | 69.693 | 70.616 | 77.478 | 83.259 | 97.971 |
| Algemene en administratieve kosten
| 30.496 | 30.814 | 33.579 | 30.751 | 24.958 | 27.322 | 21.248 | 26.138 | 19.716 | 20.665 | 186.73 |
| Verkoop- en marketingkosten
| 141.016 | 189.685 | 176.816 | 179.576 | 163.278 | 172.502 | 141.722 | 147.751 | 148.552 | 142.119 | 142.479 |
| Verkoop-, algemene en administratieve kosten
| 171.513 | 327.445 | 210.395 | 210.328 | 188.236 | 199.824 | 162.97 | 173.888 | 168.268 | 162.784 | 329.21 |
| Overige kosten
| 181.194 | -3.258 | 64.72 | 45.003 | 50.095 | 41.203 | 2.748 | 2.915 | 19.542 | 30.316 | 33.173 |
| Bedrijfskosten
| 470.929 | 431.314 | 377.511 | 356.267 | 318.245 | 316.025 | 288.698 | 294.974 | 318.668 | 314.583 | 334.642 |
| Bedrijfsresultaat
| 124.024 | 122.901 | 102.904 | 170.868 | 142.063 | 97.79 | 108.988 | 115.119 | 94.681 | 68.438 | 46.597 |
| Bedrijfsresultaat ratio
| 0.094 | 0.103 | 0.088 | 0.148 | 0.148 | 0.115 | 0.134 | 0.144 | 0.121 | 0.091 | 0.064 |
| Totaal overige inkomsten en kosten netto
| -0.58 | -0.405 | -0.717 | 0.535 | -1.915 | -0.184 | 2.748 | 2.093 | 19.311 | 29.443 | 32.794 |
| Inkomen voor belasting
| 123.444 | 122.495 | 102.187 | 171.403 | 140.149 | 97.607 | 111.736 | 117.212 | 113.991 | 97.881 | 79.391 |
| Inkomen voor belasting ratio
| 0.093 | 0.102 | 0.088 | 0.149 | 0.146 | 0.115 | 0.137 | 0.147 | 0.146 | 0.13 | 0.109 |
| Belastingkosten
| 31.272 | 19.638 | 16.776 | 21.306 | 17.844 | 8.215 | 18.797 | 24.682 | 24.501 | 20.208 | 19.74 |
| Nettowinst
| 62.637 | 80.707 | 69.842 | 132.573 | 108.976 | 77.753 | 83.385 | 85.625 | 82.55 | 70.266 | 53.235 |
| Nettowinstmarge
| 0.047 | 0.067 | 0.06 | 0.115 | 0.113 | 0.092 | 0.102 | 0.107 | 0.106 | 0.093 | 0.073 |
| WPA (Winst Per Aandeel)
| 0.25 | 0.32 | 0.28 | 0.54 | 0.5 | 0.36 | 0.51 | 0.53 | 0.51 | 0.44 | 0.33 |
| Verwaterde WPA
| 0.25 | 0.32 | 0.27 | 0.54 | 0.5 | 0.36 | 0.51 | 0.53 | 0.51 | 0.44 | 0.33 |
| EBITDA
| 256.309 | 217.901 | 179.65 | 226.33 | 185.603 | 137.752 | 152.243 | 155.627 | 153.077 | 138.985 | 77.144 |
| EBITDA ratio
| 0.194 | 0.182 | 0.154 | 0.197 | 0.193 | 0.163 | 0.187 | 0.195 | 0.196 | 0.185 | 0.106 |